Recent News for RDY - Dr. Reddy's Laboratories Ltd

Date Title
Jul 13 Indivior loses appeal to block generic Suboxone opioid treatments
Jul 12 UPDATE 1-Indivior loses appeal to block generic Suboxone opioid treatments
Jul 12 Dr. Reddy's slips 1% premarket after FDA citations at manufacturing site
Jul 11 Dr. Reddy's goes ex-dividend tomorrow
Jul 10 Amneal and Mylan weigh on generic players
Jul 10 Dr. Reddy's to release Q1 FY 20 results on July 29, 2019
Jul 9 Dr. Reddy’s launches Guaifenesin and Pseudoephedrine HCl in two strengths in U.S.
Jul 9 Dr. Reddy’s Announces the Launch of the Over-the-counter Store Brand Equivalent of Mucinex® D Extended Release Tablets in Two Strengths in the U.S. Market
Jul 3 Dr. Reddy's launches Carboprost Tromethamine Injection in U.S.
Jul 3 Dr. Reddy's Laboratories Announces First-to-market Launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) Single-dose Vial in the U.S. Market
Jul 1 Credit Suisse sees 23% upside in United Therapeutics in today's analyst action
Jun 28 Here’s What Hedge Funds Think About Dr. Reddy’s Laboratories Limited (RDY)
Jun 25 Dr. Reddy's Tobramycin Inhalation Solution now available in U.S.
Jun 25 Dr. Reddy's Laboratories Announces the Launch of Tobramycin Inhalation Solution, USP in the U.S. Market
Jun 24 Dr. Reddy's Lab launches Phytonadione Injectable Emulsion in U.S.
Jun 22 Dr. Reddy's Laboratories Announces the Launch of Phytonadione Injectable Emulsion USP, 10 mg/ml Single-Dose Ampules in the U.S. Market
Jun 14 Dr. Reddy's Inks Deal to Sell Neurology Branded Products
Jun 14 Dr. Reddy's to sell rights for migraine meds for $70M upfront
Jun 14 Dr. Reddy’s Laboratories Announces Entering into a Definitive Agreement to Sell Its Neurology Branded Products to Upsher-Smith Laboratories, LLC
Jun 14 Upsher-Smith Laboratories Enters Into Agreement To Acquire Tosymra™ (sumatriptan nasal spray) And Zembrace® SymTouch® (sumatriptan injection)
Jun 12 Teva hits 19-year low on continued pricing pressure
Jun 12 Barclays Has New Plays for Healthcare Fans
Jun 10 Dr. Reddy's Reports Positive Top-Line Data on Psoriasis Drug
Jun 10 FDA Ad Com tomorrow on utility of higher-dose opioids
Jun 10 Dr. Reddy's Lab reports positive mid-stage data in plaque psoriasis study
Back to the Main RDY Page...